Fig. 1
From: Immune cells: potential carriers or agents for drug delivery to the central nervous system
Graphical overview of the process toward immune cell-inspired nanoparticles for the treatment of central nervous system (CNS) diseases. a There are many nervous system diseases, including gliomas, ischemic stroke, Alzheimer’s disease (AD), Parkinson’s disease (PD), and several others. b The delivery of therapeutic drugs is hindered by barriers. c Peripheral immune cells migrate into CNS in the pathological state. d The migration of immune cells promotes the development of immune cell-inspired nanoparticles. e The immune cell-inspired nanoparticles provide a chance for drug delivery to the CNS